Fortress Biotech, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $79.4M | $57.3M | $80.9M | $178.3M | $305.7M | $233.4M | $136.9M | $65.5M |
| Accounts Receivable | $29.8M | $10.2M | $15.2M | $28.2M | $23.1M | $23.9M | $13.5M | $5.5M |
| Inventory | $9.6M | $14.4M | $10.2M | $14.2M | $9.9M | $1.4M | $857.0K | $678.0K |
| Total Current Assets | $123.8M | $90.4M | $117.0M | $230.4M | $346.5M | $266.2M | $156.3M | $111.2M |
| Property, Plant & Equipment | $2.5M | $3.3M | $6.5M | $13.0M | $15.1M | $11.9M | $12.4M | $12.0M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $27.6M | $31.9M | $20.3M | $27.2M | $12.6M | $14.6M | $7.4M | $1.4M |
| Total Assets | $185.5M | $144.2M | $167.5M | $294.3M | $396.5M | $333.4M | $226.4M | $141.0M |
| Liabilities | ||||||||
| Accounts Payable | $14.2M | $31.6M | $34.8M | $57.2M | $47.4M | $11.4M | $35.5M | $34.1M |
| Total Current Liabilities | $49.7M | $71.4M | $84.9M | $127.7M | $101.0M | $51.8M | $45.6M | $55.6M |
| Long-Term Debt | $52.4M | $58.0M | $60.9M | $91.7M | $42.9M | $51.7M | $84.7M | $84.4M |
| Total Liabilities | $123.4M | $145.9M | $165.9M | $244.3M | $170.6M | $136.4M | $153.9M | $121.3M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-734.1M | $-740.9M | $-694.9M | $-634.2M | $-547.5M | $-482.8M | $-436.2M | $-396.3M |
| Total Stockholders' Equity | $49.9M | $22.7M | $22.5M | $41.7M | $108.7M | $100.3M | $26.2M | $1.9M |